Adeno-associated virus type 2 as an oncogenic virus in human hepatocellular carcinoma

Jean-Charles Nault1, Shalini Datta2, Sandrine Imbeaud2

  • 1Inserm, UMR-1162, Génomique fonctionnelle des Tumeurs solides, Equipe Labellisée Ligue Contre le Cancer, Paris, F-75010 France; Université Paris Descartes, Labex Immuno-Oncology, Sorbonne Paris Cité, Faculté de Médecine, Paris, France; Université Paris 13, Sorbonne Paris Cité, UFR SMBH, F-93000 Bobigny, France; Université Paris Diderot, F-75013 Paris; APHP, Hôpitaux Universitaires Paris - Seine Saint-Denis, Site Jean Verdier, Pôle d'Activité Cancérologique Spécialisée, Service d'Hépatologie, F-93143 Bondy, France.

Insights

Adeno-associated virus type 2 (AAV2) DNA integration was found in hepatocellular carcinoma (HCC) cases. This viral DNA insertional mutagenesis occurred in key cancer driver genes, suggesting a novel role for AAV2 in liver cancer development.

Area of Science:

  • Hepatology
  • Virology
  • Oncology

Background:

  • Adeno-associated virus type 2 (AAV2) is a defective DNA virus.
  • AAV2 was previously considered non-pathogenic.
  • Hepatocellular carcinoma (HCC) is a primary liver cancer.

Purpose of the Study:

  • To investigate the potential role of AAV2 in the development of HCC.
  • To identify if AAV2 integrates into the host genome in HCC cases.

Main Methods:

  • Analysis of tumor samples from HCC patients.
  • Detection of viral DNA integration using molecular techniques.
  • Identification of host genes affected by viral insertion.

Main Results:

  • Somatic AAV2 integration was identified in a subset of 11 HCC cases.
  • Integrations were found in normal liver tissue without known predisposing factors.
  • Recurrent insertional mutagenesis occurred in cancer driver genes including TERT, CCNA2, CCNE1, TNFSF10, and KMT2B.

Conclusions:

  • Somatic AAV2 integration is associated with HCC development.
  • AAV2 can act as an insertional mutagen in liver cancer.
  • This finding suggests a novel pathogenic role for AAV2 in human cancer.

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
6.6K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.9K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
7.2K
Mechanisms of Retrovirus-induced Cancers01:51

Mechanisms of Retrovirus-induced Cancers

3.0K
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver.
6